The CD27-positive, CD38-positive, and PAX5-negative tumor-induced plasmablast-like-enriched B cell (TIPB) population regulates T cell-recruiting chemokines (CCL3, CCL4, and CCL5) and increases the number of tumor-infiltrating T cells. This evidence concerns the gene CCL5 and neoplasm.